Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Cytek Biosciences (Nasdaq: CTKB) has announced it will release its fourth quarter and full year 2024 financial results after market close on Thursday, February 27, 2025. The company will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day to discuss the results, business developments, and outlook. Interested parties can access the live audio webcast through the 'Investors' section of Cytek's website at investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 dopo la chiusura del mercato giovedì 27 febbraio 2025. L'azienda ospiterà una conferenza telefonica e una webcast alle 13:30 ora del Pacifico / 16:30 ora dell'Est nello stesso giorno per discutere i risultati, gli sviluppi aziendali e le prospettive. Le parti interessate possono accedere alla webcast audio dal vivo attraverso la sezione 'Investitori' del sito web di Cytek all'indirizzo investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 después del cierre del mercado el jueves 27 de febrero de 2025. La compañía llevará a cabo una conferencia telefónica y una transmisión en vivo a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este el mismo día para discutir los resultados, los desarrollos comerciales y las perspectivas. Las partes interesadas pueden acceder a la transmisión de audio en vivo a través de la sección 'Inversores' del sitio web de Cytek en investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB)는 2025년 2월 27일 목요일 시장 종료 후 2024년 4분기 및 연간 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 태평양 표준시 오후 1시 30분 / 동부 표준시 오후 4시 30분에 결과, 사업 개발 및 전망에 대해 논의하기 위해 컨퍼런스 콜과 웹캐스트를 개최할 예정입니다. 관심 있는 분들은 Cytek의 웹사이트 '투자자' 섹션에서 라이브 오디오 웹캐스트에 접속할 수 있습니다: investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année entière 2024 après la clôture du marché le jeudi 27 février 2025. La société organisera une conférence téléphonique et un webinaire le même jour à 13h30, heure du Pacifique / 16h30, heure de l'Est, pour discuter des résultats, des développements commerciaux et des perspectives. Les parties intéressées peuvent accéder au webinaire audio en direct via la section 'Investisseurs' du site web de Cytek à l'adresse investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB) hat angekündigt, dass es seine finanziellen Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 nach Marktschluss am Donnerstag, den 27. Februar 2025, veröffentlichen wird. Das Unternehmen wird am selben Tag um 13:30 Uhr Pazifische Zeit / 16:30 Uhr Östliche Zeit eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse, Geschäftsentwicklungen und Ausblicke zu besprechen. Interessierte Parteien können über den Bereich 'Investoren' auf der Website von Cytek auf den Live-Audio-Webcast zugreifen: investors.cytekbio.com.
- None.
- None.
FREMONT, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2024 after market close on Thursday, February 27, 2025. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.
Live audio of the webcast will be available on the “Investors” section of the company website at investors.cytekbio.com
About Cytek Biosciences
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s platform includes: its core FSP instruments, the Cytek Aurora™ and Northern Lights™ systems and the Cytek Aurora CS cell sorter; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle™ (ESP™) detection technology; the flow cytometer and imaging products under the Amnis® and Guava® brands; and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.
Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use in China and the European Union).
Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Cytek Orion, Enhanced Small Particle, ESP, Amnis and Guava are trademarks of Cytek Biosciences, Inc.
In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X (formerly Twitter) account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.
Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com
Investor Contact:
Paul D. Goodson
Head of Investor Relations
pgoodson@cytekbio.com
FAQ
When will Cytek Biosciences (CTKB) release Q4 2024 earnings?
What time is Cytek Biosciences (CTKB) Q4 2024 earnings call?
How can I access Cytek Biosciences (CTKB) Q4 2024 earnings call?
What will be discussed in Cytek Biosciences (CTKB) Q4 2024 earnings call?
